Trials / Conditions / High-risk Patients

High-risk Patients

8 registered clinical trials studyying High-risk Patients — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Suspended	Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Can NCT07071961	M.D. Anderson Cancer Center	Phase 2
Recruiting	Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients NCT06279793	GCP-Service International West GmbH	Phase 2
Recruiting	AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V61 NCT05198960	University Hospital, Brest	Phase 3
Unknown	Machine Learning-based Early Clinical Warning of High-risk Patients NCT05410171	Southeast University, China	N/A
Completed	Remimazolam and Postoperative Nausea and Vomiting in High-risk Patients NCT04861337	Peking University First Hospital	Phase 4
Completed	Intraoperative Goal-directed Blood Pressure and Dexmedetomidine on Outcomes NCT03933306	Peking University First Hospital	Phase 4
Completed	Non Absorbable Mesh Reinforcement of Midline Incision Closure in High Risk Patients, Onlay Versus Preperitonea NCT04145908	Zagazig University	N/A
Completed	Transcatheter Aortic Valve Implantation Without Predilation NCT01539746	University Hospital, Bonn	N/A